Nitro analogues of chlorambucil as potential hypoxia-selective anti-tumour drugs.

Denny Wa , Palmer Bd , Wilson Wr
Anti-cancer Drug Design 5 ( 4) 337 -349

6
1990
Inhibitors of receptor protein kinases.

Denny Wa
IDrugs : the investigational drugs journal 2 ( 6) 547

1999
ATP site-directed kinase inhibitors.

Denny Wa
IDrugs : the investigational drugs journal 1 ( 1) 10 -12

2
1998
Cellular uptake of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA).

Denny Wa , Baguley Bc , Hay Mp , Finlay Gj
Anti-cancer Drug Design 14 ( 3) 275 -280

10
1999
Topoisomerase II mediated DNA lesions induced by acridine-4-carboxamide and 2-(4-pyridyl)quinoline-8-carboxamide.

Reynolds B , McCarthy K , Beerman Ta , Denny Wa
Anti-cancer Drug Design 9 ( 1) 9 -24

11
1994
Dimeric analogues of non-cationic tricyclic aromatic carboxamides are a new class of cytotoxic agents.

Denny Wa , Baguley Bc , Gamage Sa , Spicer Ja
Anti-cancer Drug Design 14 ( 3) 281 -289

17
1999
Decarboxylation of the antitumour drugs flavone-8-acetic acid and xanthenone-4-acetic acid by nitrogen dioxide.

Everett Sa , Denny Wa , Candeias Lp , Wardman P
Anti-cancer Drug Design 9 ( 1) 68 -72

10
1994
In vitro and in vivo assessment of activity of new anilino-substituted analogues of amsacrine against Lewis lung carcinoma

Denny Wa , Baguley Bc , Rewcastle Gw , Wilson Wr
Anti-cancer Drug Design 1 ( 3) 215 -222

4
1986
14
1995
Synthesis and anti-tumour activity of topologically-related analogues of flavoneacetic acid.

Denny Wa , Baguley Bc , Rewcastle Gw , Atwell Gj
Anti-cancer Drug Design 4 ( 2) 161 -169

20
1989
The design of cobalt(III) complexes of phenazine-1-carboxamides as prointercalators and potential hypoxia-selective cytotoxins.

Denny Wa , Wilson Wr , Perrin Lc , McFadyen Wd
Anti-cancer Drug Design 14 ( 3) 231 -241

8
1999
Molecular origins of selectivity in the interaction of amsacrine-4-carboxamide with GC-rich sequences in DNA.

Waring Mj , Denny Wa , Bailly C
Anti-cancer Drug Design 11 ( 8) 611 -624

2
1996
Steric constraints for DNA binding and biological activity in the amsacrine series.

Denny Wa , Baguley Bc , Twigden Sj
Anti-cancer Drug Design 1 ( 2) 125 -132

11
1986
Amsacrine analogues with extended chromophores: DNA binding and anti-tumour activity.

Denny Wa , Baguley Bc
Anti-cancer Drug Design 2 ( 1) 61 -70

5
1987